CLDI
Calidi Biotherapeutics, Inc.
Company overview
- Market capitalization
- —
- Employees
- 29
- Latest publication
- 2026-09-29
About Calidi Biotherapeutics, Inc.
Calidi Biotherapeutics, Inc., a biotechnology company, develops targeted therapies to deliver genetic medicines to distal sites of disease. The company offers CLD-101, which is in Phase 1b/2 clinical trial for the treatment of newly diagnosed high grade glioma, as well as in Phase 1 dose-escalation clinical trial for recurrent high-grade glioma; CLD-201 product for solid tumors, such as breast cancer, head and neck cancer, and sarcoma; and CLD-401 for the treatment of metastatic solid tumors. It also offers oncolytic virus platforms, such as NeuroNova and SuperNova. Calidi Biotherapeutics, Inc. was founded in 2014 and is headquartered in San Diego, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 1,504,000USD | 0USD | 0USD |
| Cost Of Revenue | 426,000USD | 423,000USD | 427,000USD | 407,000USD | 394,000USD | 393,000USD | 390,000USD | 374,000USD |
| Gross Profit | -426,000USD | -423,000USD | -427,000USD | -407,000USD | -394,000USD | -393,000USD | -390,000USD | -374,000USD |
| Research Development | 2,587,000USD | 2,358,000USD | 2,361,000USD | 2,593,000USD | 2,425,000USD | 1,815,000USD | 2,153,000USD | 2,167,000USD |
| Selling General Administrative | 1,600,000USD | 2,108,000USD | 2,687,000USD | 3,071,000USD | 2,637,000USD | 2,211,000USD | 3,073,000USD | 3,605,000USD |
| Total Operating Expenses | 3,761,000USD | 4,466,000USD | 5,048,000USD | 5,664,000USD | 5,062,000USD | 3,633,000USD | 5,226,000USD | 5,772,000USD |
| Operating Income | -4,187,000USD | -4,466,000USD | -5,048,000USD | -5,664,000USD | -5,062,000USD | -4,026,000USD | -5,226,000USD | -5,772,000USD |
| Interest Expense | 38,000USD | 42,000USD | 41,000USD | 52,000USD | 72,000USD | 175,000USD | 232,000USD | 273,000USD |
| Net Interest Income | -38,000USD | -42,000USD | -41,000USD | -52,000USD | -72,000USD | -175,000USD | -232,000USD | -273,000USD |
| Income Before Tax | -4,104,000USD | -4,061,000USD | -5,171,000USD | -5,757,000USD | -5,059,000USD | -4,144,999USD | -5,070,000USD | -5,759,000USD |
| Income Tax Expense | 4,000USD | -2,000USD | 10,000USD | 4,000USD | 3,000USD | 3,000USD | -1,000USD | 8,000USD |
| Tax Provision | 4,000USD | -2,000USD | 10,000USD | 4,000USD | 3,000USD | 3,000USD | -1,000USD | 8,000USD |
| Net Income | -4,108,000USD | -4,056,000USD | -5,149,000USD | -5,715,000USD | -4,986,000USD | -4,097,000USD | -5,054,000USD | -5,767,000USD |
| Net Income From Continuing Ops | -4,108,000USD | -4,059,000USD | -5,181,000USD | -5,761,000USD | -5,062,000USD | -4,148,000USD | -5,069,000USD | -5,767,000USD |
| Ebit | -4,187,000USD | -4,019,000USD | -5,130,000USD | -5,705,000USD | -4,987,000USD | -3,970,000USD | -4,838,000USD | -5,486,000USD |
| Ebitda | -3,761,000USD | -3,596,000USD | -4,703,000USD | -5,298,000USD | -4,593,000USD | -3,577,000USD | -4,448,000USD | -5,108,000USD |
| Depreciation And Amortization | 426,000USD | 423,000USD | 427,000USD | 407,000USD | 394,000USD | 393,000USD | 390,000USD | 378,000USD |
| Reconciled Depreciation | 426,000USD | 423,000USD | 427,000USD | 407,000USD | 394,000USD | 393,000USD | 390,000USD | 378,000USD |
| Total Other Income Expense Net | 83,000USD | 405,000USD | -123,000USD | -93,000USD | 3,000USD | -118,999USD | 156,000USD | 13,000USD |
| Minority Interest | 0USD | 3,000USD | 32,000USD | 46,000USD | 76,000USD | 51,000USD | 15,000USD | 0USD |
| Selling And Marketing Expenses | — | — | — | — | — | 374,000USD | — | 374,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 45,000USD | 449,000USD | 0USD |
| Cost Of Revenue | 1,651,000USD | 1,535,000USD | 1,256,000USD | 274,000USD | 94,000USD | 0USD |
| Gross Profit | -1,651,000USD | -1,535,000USD | -1,256,000USD | -229,000USD | 355,000USD | 0USD |
| Research Development | 9,737,000USD | 8,878,000USD | 13,008,000USD | 7,257,000USD | 4,674,000USD | 3,182,000USD |
| Selling General Administrative | 10,503,000USD | 12,898,000USD | 15,984,000USD | 15,902,000USD | 6,163,000USD | 3,591,000USD |
| Unclassified Operating Expenses | -1,651,000USD | — | -1,256,000USD | — | — | — |
| Total Operating Expenses | 18,589,000USD | 21,776,000USD | 27,736,000USD | 22,899,000USD | 10,837,000USD | 6,773,000USD |
| Operating Income | -20,240,000USD | -21,776,000USD | -28,992,000USD | -23,128,000USD | -10,482,000USD | -6,773,000USD |
| Interest Expense | 207,000USD | 933,000USD | 3,749,000USD | 158,000USD | 614,000USD | 163,000USD |
| Net Interest Income | -207,000USD | -933,000USD | -3,749,000USD | -122,000USD | -614,000USD | -163,000USD |
| Income Before Tax | -20,048,000USD | -22,195,000USD | -29,200,000USD | -25,416,000USD | 3,397,750USD | -7,933,000USD |
| Income Tax Expense | 15,000USD | 14,000USD | 16,000USD | 11,000USD | 11,000USD | 4,000USD |
| Tax Provision | 15,000USD | 14,000USD | 16,000USD | 17,000USD | 11,000USD | 4,000USD |
| Net Income | -19,906,000USD | -22,143,000USD | -29,216,000USD | -25,427,000USD | -10,933,000USD | -7,937,000USD |
| Net Income From Continuing Ops | -20,063,000USD | -22,209,000USD | -29,216,000USD | -21,160,000USD | -10,933,000USD | -7,937,000USD |
| Ebit | -20,240,000USD | -21,262,000USD | -25,451,000USD | -25,258,000USD | -9,606,000USD | -6,773,000USD |
| Ebitda | -18,589,000USD | -19,727,000USD | -24,195,000USD | -24,998,000USD | -9,450,000USD | -6,666,000USD |
| Depreciation And Amortization | 1,651,000USD | 1,535,000USD | 1,256,000USD | 260,000USD | 156,000USD | 107,000USD |
| Reconciled Depreciation | 1,651,000USD | 1,535,000USD | 1,256,000USD | 207,000USD | 153,000USD | 117,000USD |
| Total Other Income Expense Net | 192,000USD | -419,000USD | -208,000USD | -2,288,000USD | 13,879,750USD | -1,160,000USD |
| Minority Interest | 157,000USD | 66,000USD | 0USD | — | — | — |
| Selling And Marketing Expenses | — | — | — | 260,000USD | — | — |
| Net Income Applicable To Common Shares | — | — | — | -25,427,000USD | -10,933,000USD | -7,937,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 7,204,000USD | 9,591,000USD | 8,857,000USD | 14,029,000USD | 9,351,000USD | 15,064,000USD | 14,182,000USD | 6,657,000USD |
| Total Current Assets | 5,428,000USD | 7,353,000USD | 6,256,000USD | 11,028,000USD | 6,049,000USD | 11,489,000USD | 10,227,000USD | 2,221,000USD |
| Other Current Assets | 1,357,000USD | 722,000USD | 656,000USD | 653,000USD | 720,000USD | 878,000USD | 636,000USD | 324,000USD |
| Other Non Current Assets | 9,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 4,071,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 3,237,000USD | 3,836,000USD | 3,935,000USD | 5,193,000USD | 5,353,000USD | 5,426,000USD | 9,496,000USD | 11,579,000USD |
| Total Stockholder Equity | 3,133,000USD | 4,935,000USD | 3,759,000USD | 6,918,000USD | 1,764,000USD | 6,941,000USD | 1,534,000USD | -10,283,000USD |
| Total Equity Including Noncontrolling Interest | 3,133,000USD | — | — | — | — | — | — | — |
| Short Long Term Debt | 45,000USD | — | — | 405,000USD | 775,000USD | 1,132,000USD | 3,176,000USD | 3,090,000USD |
| Property Plant Equipment Net | 1,767,000USD | 1,342,000USD | 1,682,000USD | 2,012,000USD | 2,333,000USD | 3,431,000USD | 2,934,000USD | 4,219,000USD |
| Short Term Debt | 1,009,000USD | 1,504,000USD | 1,516,000USD | 2,276,000USD | 2,192,000USD | 2,453,000USD | 4,446,000USD | 4,322,000USD |
| Retained Earnings | -149,889,000USD | -145,729,000USD | -141,621,000USD | -137,565,000USD | -132,416,000USD | -126,701,000USD | -121,715,000USD | -117,618,000USD |
| Accumulated Other Comprehensive Income | -26,000USD | -22,000USD | -13,000USD | -13,000USD | -13,000USD | -26,000USD | -28,000USD | -74,000USD |
| Total Liab | — | 4,656,000USD | 5,098,000USD | 6,831,000USD | 7,275,000USD | 7,765,000USD | 12,214,000USD | 16,455,000USD |
| Other Current Liab | — | 1,432,000USD | 1,806,000USD | 1,774,000USD | 1,934,000USD | 1,775,000USD | 2,978,000USD | 3,683,000USD |
| Common Stock | — | 1,000USD | 1,000USD | 1,000USD | — | 3,000USD | 2,000USD | 1,000USD |
| Capital Stock | — | 1,000USD | 1,000USD | 1,000USD | 0USD | 3,000USD | 2,000USD | 1,000USD |
| Cash | — | 6,631,000USD | 5,600,000USD | 10,375,000USD | 5,279,000USD | 10,561,000USD | 9,591,000USD | 1,897,000USD |
| Cash And Short Term Investments | — | 6,631,000USD | 5,600,000USD | 10,375,000USD | 5,279,000USD | 10,561,000USD | 9,591,000USD | 1,897,000USD |
| Net Debt | — | -4,974,000USD | -3,636,000USD | -7,262,000USD | -1,268,000USD | -5,856,000USD | -2,555,000USD | 7,125,000USD |
| Short Long Term Debt Total | — | 1,657,000USD | 1,964,000USD | 3,113,000USD | 4,011,000USD | 4,705,000USD | 7,036,000USD | 9,022,000USD |
| Long Term Debt | — | 600,000USD | 600,000USD | 600,000USD | 600,000USD | 600,000USD | 600,000USD | 2,373,000USD |
| Accounts Payable | — | 900,000USD | 613,000USD | 1,143,000USD | 1,227,000USD | 1,198,000USD | 2,072,000USD | 3,574,000USD |
| Property Plant Equipment Gross | — | 3,853,000USD | 4,257,000USD | 4,573,000USD | 4,869,000USD | 4,897,000USD | 5,158,000USD | 5,519,000USD |
| Common Stock Shares Outstanding | — | 10,308,000shares | 7,216,994shares | 4,907,000shares | 2,877,000shares | 2,248,138shares | 664,415shares | 649,392shares |
| Non Current Assets Total | — | 2,238,000USD | 2,601,000USD | 3,001,000USD | 3,302,000USD | 3,575,000USD | 3,955,000USD | 4,436,000USD |
| Non Current Liabilities Total | — | 820,000USD | 1,163,000USD | 1,638,000USD | 1,922,000USD | 2,339,000USD | 2,718,000USD | 4,876,000USD |
| Non Currrent Assets Other | — | 777,000USD | 800,000USD | 989,000USD | 867,000USD | 21,000USD | 892,000USD | 88,000USD |
| Net Working Capital | — | 3,517,000USD | 2,321,000USD | 5,835,000USD | 696,000USD | 6,063,000USD | 731,000USD | -9,358,000USD |
| Unclassified Equity | — | 150,684,000USD | 145,391,000USD | 144,494,000USD | 134,193,000USD | 133,662,000USD | 123,273,000USD | 107,407,000USD |
| Unclassified Non Current Liabilities | — | — | — | 1,038,000USD | 1,322,000USD | 1,739,000USD | 2,118,000USD | 2,503,000USD |
| Net Receivables | — | — | — | — | 50,000USD | 50,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | — | -1,132,000USD | -3,176,000USD | -4,472,000USD |
| Current Deferred Revenue | — | — | — | — | — | — | — | 1,382,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 8,857,000USD | 14,182,000USD | 10,019,000USD | 2,597,000USD | 3,391,000USD | 1,852,000USD |
| Other Current Assets | 656,000USD | 636,000USD | 894,000USD | 414,000USD | 603,000USD | 93,000USD |
| Total Liab | 5,098,000USD | 12,214,000USD | 18,254,000USD | 53,037,000USD | 26,002,000USD | 24,332,000USD |
| Total Stockholder Equity | 3,759,000USD | 1,534,000USD | -8,235,000USD | -50,440,000USD | -22,611,000USD | -22,480,000USD |
| Other Current Liab | 1,806,000USD | 2,978,000USD | 5,432,000USD | 35,324,000USD | 20,197,000USD | 2,788,000USD |
| Common Stock | 1,000USD | 2,000USD | 4,000USD | 2,000USD | 2,000USD | 2,000USD |
| Capital Stock | 1,000USD | 2,000USD | 4,000USD | 2,000USD | 2,000USD | 2,000USD |
| Retained Earnings | -141,621,000USD | -121,715,000USD | -99,572,000USD | -70,356,000USD | -44,929,000USD | -34,437,000USD |
| Cash | 5,600,000USD | 9,591,000USD | 2,049,000USD | 372,000USD | 2,137,000USD | 420,000USD |
| Cash And Short Term Investments | 5,600,000USD | 9,591,000USD | 2,049,000USD | 372,000USD | 2,137,000USD | 420,000USD |
| Total Current Assets | 6,256,000USD | 10,227,000USD | 4,303,000USD | 786,000USD | 2,740,000USD | 513,000USD |
| Total Current Liabilities | 3,935,000USD | 9,496,000USD | 10,232,000USD | 42,989,000USD | 25,959,000USD | 8,888,000USD |
| Net Debt | -3,036,000USD | -2,555,000USD | 5,187,000USD | 5,616,000USD | 3,044,000USD | 11,301,000USD |
| Short Term Debt | 1,516,000USD | 4,446,000USD | 1,923,000USD | 5,541,000USD | 5,138,000USD | 5,278,000USD |
| Short Long Term Debt Total | 2,564,000USD | 7,036,000USD | 7,236,000USD | 5,988,000USD | 5,181,000USD | 11,721,000USD |
| Long Term Debt | 600,000USD | 600,000USD | 2,060,000USD | — | — | 6,371,000USD |
| Accounts Payable | 613,000USD | 2,072,000USD | 2,877,000USD | 2,124,000USD | 624,000USD | 822,000USD |
| Property Plant Equipment Net | 1,682,000USD | 2,934,000USD | 5,343,000USD | 1,086,000USD | 585,000USD | 723,000USD |
| Property Plant Equipment Gross | 4,257,000USD | 5,158,000USD | 6,336,000USD | 1,717,000USD | 975,000USD | 999,000USD |
| Accumulated Other Comprehensive Income | -13,000USD | -28,000USD | -47,000USD | -14,000USD | -1,000USD | 6,000USD |
| Common Stock Shares Outstanding | 4,302,000shares | 664,415shares | 140,162shares | 70,591shares | 238,625shares | 2,980,241shares |
| Non Current Assets Total | 2,601,000USD | 3,955,000USD | 5,716,000USD | 1,811,000USD | 651,000USD | 1,339,000USD |
| Non Current Liabilities Total | 1,163,000USD | 2,718,000USD | 8,022,000USD | 10,048,000USD | 43,000USD | 15,444,000USD |
| Non Currrent Assets Other | 800,000USD | 892,000USD | 143,000USD | 725,000USD | 66,000USD | 616,000USD |
| Net Working Capital | 2,321,000USD | 731,000USD | -5,929,000USD | -42,203,000USD | -23,219,000USD | -8,375,000USD |
| Unclassified Equity | 145,391,000USD | 123,273,000USD | 91,376,000USD | 19,926,000USD | 22,315,000USD | 11,947,000USD |
| Short Long Term Debt | — | 3,176,000USD | 807,000USD | 5,425,000USD | 5,002,000USD | 4,942,000USD |
| Unclassified Current Liabilities | — | -3,176,000USD | — | -5,425,000USD | -5,002,000USD | -6,630,000USD |
| Unclassified Non Current Liabilities | — | 2,118,000USD | 3,924,000USD | 10,048,000USD | — | 8,457,000USD |
| Net Receivables | — | — | 1,360,000USD | 870USD | — | — |
| Non Current Liabilities Other | — | — | 2,038,000USD | — | — | — |
| Other Assets | — | — | — | 725,000USD | 1USD | 616,000USD |
| Net Tangible Assets | — | — | — | -50,440,000USD | -31,612,000USD | -22,480,000USD |
| Current Deferred Revenue | — | — | — | — | -5,138,000USD | 1,688,000USD |
| Deferred Long Term Liab | — | — | — | — | — | 616,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 864,000USD |
| Stock Based Compensation | 388,000USD |
| Change To Account Receivables | 15,000USD |
| Change To Liabilities | -427,000USD |
| Change In Working Capital | -6,000USD |
| Operating Cash Flow | -8,469,000USD |
| Investing Cash Flow | -38,000USD |
| Net Debt Issuance | -91,000USD |
| Unclassified Financing Cash Flow | 7,079,000USD |
| Financing Cash Flow | 6,988,000USD |
| Effect Of Forex Changes On Cash | -10,000USD |
| Change In Cash | -1,529,000USD |
| End Cash Flow | 4,290,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -4,417,000USD | -4,056,000USD | -5,149,000USD | -5,761,000USD | -5,062,000USD | -4,148,000USD | -5,069,000USD | -5,767,000USD |
| Depreciation | 426,000USD | 423,000USD | 427,000USD | 407,000USD | 394,000USD | 393,000USD | 390,000USD | 378,000USD |
| Stock Based Compensation | 231,000USD | 450,000USD | 529,000USD | 522,000USD | 607,000USD | 626,000USD | 692,000USD | 751,000USD |
| Other Non Cash Items | 492,000USD | 117,000USD | 597,000USD | 19,000USD | -35,000USD | -44,000USD | -371,000USD | -1,110,000USD |
| Change In Working Capital | -617,000USD | -1,528,000USD | -113,000USD | -67,000USD | -3,035,000USD | -2,250,000USD | -588,000USD | 1,917,000USD |
| Total Cash From Operating Activities | -4,115,999USD | -5,044,000USD | -4,238,000USD | -4,880,000USD | -7,131,000USD | -5,423,000USD | -4,946,000USD | -3,831,000USD |
| Capital Expenditures | -5,000USD | -29,000USD | -27,000USD | -57,000USD | -7,000USD | -5,000USD | -6,000USD | -5,000USD |
| Free Cash Flow | -4,121,000USD | -5,073,000USD | -4,265,000USD | -4,937,000USD | -7,138,000USD | -5,428,000USD | -4,952,000USD | -3,836,000USD |
| Total Cashflows From Investing Activities | -5,000USD | -79,000USD | -27,000USD | -57,000USD | -7,000USD | -5,000USD | -6,000USD | -5,000USD |
| Net Borrowings | -44,000USD | -27,000USD | -404,000USD | -392,000USD | -1,667,000USD | -19,000USD | 582,000USD | — |
| Total Cash From Financing Activities | 5,159,000USD | 340,000USD | 9,480,000USD | -469,000USD | 8,108,000USD | 13,106,000USD | 6,046,000USD | 3,013,000USD |
| Dividends Paid | -309,000USD | — | -5,673,000USD | 0USD | 0USD | — | 0USD | 0USD |
| Issuance Of Capital Stock | 5,369,000USD | 488,000USD | 6,090,000USD | 0USD | 10,076,000USD | 11,659,000USD | 1,000,000USD | 5,406,000USD |
| Change In Cash | 1,031,000USD | -4,775,000USD | 5,096,000USD | -5,400,000USD | 970,000USD | 7,694,000USD | 1,061,000USD | -806,000USD |
| Begin Period Cash Flow | 5,700,000USD | 10,475,000USD | 5,379,000USD | 10,779,000USD | 9,809,000USD | 2,115,000USD | 1,054,000USD | 2,049,000USD |
| End Period Cash Flow | 6,731,000USD | 5,700,000USD | 10,475,000USD | 5,379,000USD | 10,779,000USD | 9,809,000USD | 2,115,000USD | 1,243,000USD |
| Other Cashflows From Investing Activities | -5,000USD | — | -27,000USD | — | — | — | — | — |
| Other Cashflows From Financing Activities | -171,000USD | -27,000USD | -29,000USD | -80,000USD | -301,000USD | 1,466,000USD | 4,464,000USD | -7,812,000USD |
| Investments | — | — | -27,000USD | -57,000USD | -7,000USD | -5,000USD | -6,000USD | 0USD |
| Unclassified Financing Cash Flow | — | — | 9,496,000USD | — | — | — | — | 5,419,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -20,063,000USD | -22,209,000USD | -29,216,000USD | -25,427,000USD | -10,933,000USD | -7,937,000USD |
| Depreciation | 1,651,000USD | 1,535,000USD | 1,256,000USD | 260,000USD | 153,000USD | 184,000USD |
| Stock Based Compensation | 2,108,000USD | 2,957,000USD | 4,809,000USD | 6,143,000USD | 1,327,000USD | 968,000USD |
| Other Non Cash Items | -246,000USD | -279,000USD | 2,410,000USD | 8,384,000USD | 582,000USD | 1,014,000USD |
| Change In Working Capital | -4,743,000USD | -1,698,000USD | -6,242,000USD | 3,569,000USD | 1,097,000USD | 945,000USD |
| Total Cash From Operating Activities | -21,293,000USD | -19,694,000USD | -26,983,000USD | -13,214,000USD | -7,774,000USD | -4,826,000USD |
| Capital Expenditures | -120,000USD | -16,000USD | -585,000USD | -428,000USD | -206,000USD | -351,000USD |
| Free Cash Flow | -21,413,000USD | -19,710,000USD | -27,568,000USD | -13,642,000USD | -7,980,000USD | -5,177,000USD |
| Total Cashflows From Investing Activities | -170,000USD | -16,000USD | -478,000USD | -494,000USD | -215,000USD | -388,000USD |
| Net Borrowings | -2,490,000USD | 1,918,000USD | 899,000USD | 1,381,000USD | 1,750,000USD | 1,879,000USD |
| Total Cash From Financing Activities | 17,459,000USD | 27,365,000USD | 29,044,000USD | 12,087,000USD | 9,810,000USD | 4,697,000USD |
| Dividends Paid | -5,673,000USD | -1,671,000USD | — | — | — | — |
| Issuance Of Capital Stock | 16,654,000USD | 18,065,000USD | 27,260,000USD | 0USD | 35,000USD | 2,997,000USD |
| Change In Cash | -3,990,000USD | 7,642,000USD | 1,577,000USD | -590,653USD | 1,817,000USD | -514,000USD |
| Begin Period Cash Flow | 9,809,000USD | 2,167,000USD | 590,000USD | 1,062,653USD | 420,000USD | 934,000USD |
| End Period Cash Flow | 5,819,000USD | 9,809,000USD | 2,167,000USD | 472,000USD | 2,237,000USD | 420,000USD |
| Other Cashflows From Investing Activities | 124,000USD | -16,000USD | 98,000USD | -190,076,529USD | -9,000USD | -37,000USD |
| Other Cashflows From Financing Activities | -846,000USD | 9,053,000USD | 25,382,000USD | -58,000USD | 8,025,000USD | -179,000USD |
| Unclassified Financing Cash Flow | 9,814,000USD | — | -24,497,000USD | 10,764,000USD | — | 3,172,000USD |
| Investments | — | -16,000USD | -478,000USD | -360,000USD | -215,000USD | -388,000USD |
| Change To Account Receivables | — | — | — | -870USD | — | — |
| Change To Liabilities | — | — | — | 1,624,000USD | -239,000USD | 293,000USD |
| Unclassified Operating Cash Flow | — | — | — | -6,143,000USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 190,370,529USD | — | — |
| Sale Purchase Of Stock | — | — | — | — | 0USD | -175,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.